1. Home
  2. DSS vs CNSP Comparison

DSS vs CNSP Comparison

Compare DSS & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DSS Inc.

DSS

DSS Inc.

N/A

Current Price

$0.94

Market Cap

10.7M

ML Signal

N/A

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

N/A

Current Price

$4.64

Market Cap

3.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DSS
CNSP
Founded
1984
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.7M
3.8M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
DSS
CNSP
Price
$0.94
$4.64
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$20.00
AVG Volume (30 Days)
254.6K
73.2K
Earning Date
11-14-2025
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$22,046,000.00
N/A
Revenue This Year
$14.93
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.53
N/A
52 Week Low
$0.72
$4.34
52 Week High
$1.90
$114.00

Technical Indicators

Market Signals
Indicator
DSS
CNSP
Relative Strength Index (RSI) 45.19 28.10
Support Level $0.88 $5.76
Resistance Level $0.97 $5.61
Average True Range (ATR) 0.16 0.45
MACD -0.02 -0.17
Stochastic Oscillator 5.92 5.42

Price Performance

Historical Comparison
DSS
CNSP

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: